Haemonetics (HAE) Change in Accured Expenses (2009 - 2026)

Haemonetics' Change in Accured Expenses history runs 18 years deep, the most recent figure standing at $20.3 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 15.41% year-over-year to $20.3 million in Q1 2026; TTM through Mar 2026 was -$16.6 million, a 13.73% increase from a year earlier, with the FY2026 full-year figure at -$16.6 million, up 13.73% from the prior year.
• Change in Accured Expenses advanced to $20.3 million in Q1 2026 per HAE's latest filing, from -$6.7 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $49.5 million in Q1 2024 and bottomed at -$47.9 million in Q2 2025.
• The 5-year median for Change in Accured Expenses is $6.7 million (2022), against an average of $4.5 million.
• Across the five-year window, Change in Accured Expenses surged 836.31% in 2022 and sank 424.4% in 2023, its largest moves.
• Year by year, Change in Accured Expenses stood at $7.3 million in 2022, then sank by 424.4% to -$23.7 million in 2023, then soared by 113.96% to $3.3 million in 2024, then slumped by 302.36% to -$6.7 million in 2025, then jumped by 403.49% to $20.3 million in 2026.
• Per Business Quant, the three latest HAE Change in Accured Expenses figures stand at $20.3 million (Q1 2026), -$6.7 million (Q4 2025), and $17.7 million (Q3 2025).